Trials / Withdrawn
WithdrawnNCT05069636
Lymphatic Osteopathic Manipulative Medicine to Enhance Coronavirus (COVID-19) Vaccination Efficacy
Lymphatic Osteopathic Manipulative Medicine to Enhance COVID-19 Vaccination Efficacy
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Rowan University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this project is to study the impact of Osteopathic Manipulative Medicine (OMM) treatments, such as lymphatic myofascial release and thoracic pump techniques severe acute respiratory syndrome-associated coronavirus 2 (SARS-Cov-2) antibody levels in patients who receive the mRNA-1273 (Moderna) COVID-19 vaccine and to consider if these OMM strategies allow a stronger more robust immune response.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Lymphatic OMM | Patients receive lymphatic myofascial release and thoracic pump techniques. |
| OTHER | Light Touch | Patients receive a series of light touch techniques. |
Timeline
- Start date
- 2021-02-14
- Primary completion
- 2023-02-28
- Completion
- 2023-02-28
- First posted
- 2021-10-06
- Last updated
- 2022-10-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05069636. Inclusion in this directory is not an endorsement.